Skip to main content
Signal8

Vincerx Pharma, Inc. (VINC)

Sector: Biotechnology

Industry: Biotechnology

Vincerx Pharma, Inc. logo

Vincerx Pharma, Inc.

OTC:VINCHealthcare
+0.00%$0.0150
CLOSED
Mkt Cap$79K
EV-
Float5.23M
O/S5.23M
VOL663 sh
$ Vol$10
RVOL0.50×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Vincerx Pharma, Inc. logoOTC:VINCClosed$0.0150+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.01500.01500.01500.0150663
Nov 12, 20260.01500.01500.01500.01505,500
Nov 10, 20260.01500.01500.01500.01502,111
Nov 9, 20260.01500.01500.01500.0150177
Nov 6, 20260.01500.01500.01500.01501,070
Nov 5, 20260.01500.01500.01500.01501,870
Nov 4, 20260.01500.01500.01500.0150428
Oct 29, 20260.01500.01500.01500.01501,000
Oct 28, 20260.01500.01500.01500.0150175
Oct 27, 20260.01500.01500.01500.01502,205
Oct 23, 20260.01500.01500.01500.0150251
Oct 22, 20260.01500.01500.01500.0150460
Oct 16, 20260.01500.01500.01500.01501,450
Oct 9, 20260.01500.02570.01500.025710,977
Oct 7, 20260.01500.01500.01500.0150101
Oct 5, 20260.01500.01500.01500.0150104
Oct 2, 20260.01500.01500.01500.0150801
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
7
HOLD
0
SELL
0
TOTAL7
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(1)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Insider0.0%
Unattributed (incl. retail)100.0%
Sources: Form 4, 13D/13GO/S: 5.2M · date not recorded
Insiders & Institutional Holders

Insiders

About

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.

Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer.

The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Key Metrics
Market Cap$78,514
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryUSUS
IPO DateApr 21, 2025
Shares Outstanding5.23M
Authorized Shares
Float5.23M
52-Week Range
$0.0100$0.0257
$0.0150(32nd percentile)
Volume
Average Daily Volume1.33K
663 today vs 1.33K avg(-50%)

30d Avg

1.33K

60d Avg

1.45K

90d Avg

1.52K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Vincerx Pharma, Inc. (OTC: VINC) traded at $0.0150 on Nov 16, 2026, unchanged from the previous close of $0.0150. 52-week range: $0.0100 to $0.0257. The company is in the Healthcare sector (Biotechnology).